StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.67−0.10 (-12.58%)

Close on Nov 17, 2026Market cap $7.93MP/E –Yield –

Radiopharm Theranostics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2026 it was $2.77M, down 23.8% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$2.77M-23.8%
FY2025Jun 30, 2025$3.63M+1114.3%
FY2024Jun 30, 2024$299.23K+2.3%
FY2023Jun 30, 2023$292.36K–

More Radiopharm Theranostics figures

See a number that looks wrong?